𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sa1307 Incidence, Outcome and Factors Affecting Post Liver Transplant Cholestatic Hepatitis C

✍ Scribed by Zalawadia, Ashish; Nagai, Shunji; Salami, Augustine; Parekh, Ravish; Kuchipudi, Aishwarya; Tabbal, Mahmoud; Nakamura, Mio; Altshuler, David; Peterson, Ed; Raoufi, Mohammad; Abouljoud, Marwan; Schnickel, Gabriel T.; Brown, Kimberly A.; Moonka, Dilip K.; Jafri, Syed-Mohammed

Book ID
122326537
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
657 KB
Volume
146
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Incidence, prevalence, and clinical outc
Incidence, prevalence, and clinical outcome of hepatitis GB-C virus infection in liver transplant patients
✍ Kallinowski, Birgit ;Buhrmann, Christine ;Seipp, Stefanie ;Goeser, Tobias ;Strem πŸ“‚ Article πŸ“… 1998 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 112 KB πŸ‘ 2 views

A novel RNA virus of the Flaviviridae family has been discovered recently and designated hepatitis GB-C virus (GBV-C). Previous studies have reported that GBV-C is associated with posttransfusion hepatitis, chronic viral hepatitis, and cryptogenic hepatitis. However, the clinical significance of GBV

Post–liver transplant cholestatic hepati
Post–liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteria
✍ Tarun K. Narang; Will Ahrens; Mark W. Russo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 209 KB

Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis C. However, recurrent hepatitis C after liver transplantation is nearly universal. Cirrhosis may develop in 20% of recipients within 5 years, and recurrent hepatitis